Benzene Ring And The Phosphorus Bonded Directly To The Same Chalcogen (i.e., The Carbon Of The Phosphorus Ester Group Is Part Of A Benzene Ring) Patents (Class 558/200)
  • Patent number: 9000077
    Abstract: A phosphazene compound having a vinyl group is manufactured by a reaction between a vinyl compound and a phosphazene compound having a hydroxyl group and added to a resin composition for manufacturing a prepreg or a resin film so as to be applicable to copper-clad laminates and printed circuit boards to thereby achieve satisfactory circuit laminate properties, namely low coefficient of thermal expansion, low dielectric properties, heat resistant, fire resistant, and halogen-free.
    Type: Grant
    Filed: June 19, 2013
    Date of Patent: April 7, 2015
    Assignee: Elite Material Co., Ltd.
    Inventor: Chen-Yu Hsieh
  • Publication number: 20140323624
    Abstract: A phosphazene compound having a vinyl group is manufactured by a reaction between a vinyl compound and a phosphazene compound having a hydroxyl group and added to a resin composition for manufacturing a prepreg or a resin film so as to be applicable to copper-clad laminates and printed circuit boards to thereby achieve satisfactory circuit laminate properties, namely low coefficient of thermal expansion, low dielectric properties, heat resistant, fire resistant, and halogen-free.
    Type: Application
    Filed: June 19, 2013
    Publication date: October 30, 2014
    Inventor: CHEN-YU HSIEH
  • Publication number: 20140309164
    Abstract: Deuterated nucleoside analogs of Formula (I) and the pharmaceutically acceptable salts thereof are provided by this disclosure The variables, e.g., B1, Y, R1, R2, R3, R3?, R4, R5, R6, R7, R8, and R9 carry definitions set forth in the disclosure. Compounds of Formula (I) are deuterated at one or more positions and the deuterium enrichment at each deuterated positions is at least 50%. Compounds and salts of Formula (I) are useful for treating viral infections, including HCV infections.
    Type: Application
    Filed: April 14, 2014
    Publication date: October 16, 2014
    Applicant: Achillion Pharmaceuticals, Inc.
    Inventors: Milind Deshpande, Jason Allan Wiles, Akihiro Hashimoto, Avinash Phadke
  • Publication number: 20130281687
    Abstract: Disclosed herein are methods of preparing a phosphorothioate nucleotide analog, which are useful in treating diseases and/or conditions such as viral infections.
    Type: Application
    Filed: March 18, 2013
    Publication date: October 24, 2013
    Inventors: ALIOS BIOPHARMA, INC., VERTEX PHARMACEUTICALS INC.
  • Publication number: 20130165644
    Abstract: Disclosed herein are nucleoside phosphoramidates and their use as agents for treating viral diseases. These compounds are inhibitors of RNA-dependent 5 RNA viral replication and are useful as inhibitors of HCV NS5B polymerase, as inhibitors of HCV replication and for treatment of hepatitis C infection in mammals.
    Type: Application
    Filed: January 25, 2013
    Publication date: June 27, 2013
    Applicant: GILEAD PHARMASSET LLC
    Inventor: GILEAD PHARMASSET LLC
  • Patent number: 6569929
    Abstract: The present invention relates to a method for preparing phosphoramides having a glass transition temperature in one embodiment of at least about 0° C., in another embodiment of at least about 10° C., and in still another embodiment of at least about 20° C., the phosphoramides being substantially free of acidic, basic, or halide impurities, or their precursors. The invention also relates to resin compositions comprising at least one thermoplastic resin and at least one phosphoramide having a glass transition temperature of at least about 0° C., wherein the phosphoramide is prepared by the method of the invention.
    Type: Grant
    Filed: May 4, 2001
    Date of Patent: May 27, 2003
    Assignee: General Electric Company
    Inventors: Neal Steven Falcone, John Robert Campbell, James Ross Fishburn
  • Patent number: 6528559
    Abstract: This invention provides a halogen-free flame retardant which advantageously has a high melting point and a low volatility and does not impair the inherent properties of resins. The flame retardant of the invention is a phosphazene compound crosslinked with a crosslinking group such as a phenylene group, wherein each of the crosslinking groups is interposed between the two oxygen groups left after the elimination of phenyl groups from the phosphazene compound; the crosslinked phenoxyphosphazene compound does not have any free hydroxyl groups (derived from crosslinking groups); and the amount of the phenyl groups in the crosslinked compound is 50 to 99.9%, based on the total number of the phenyl groups in the phosphazene compound.
    Type: Grant
    Filed: February 12, 2001
    Date of Patent: March 4, 2003
    Assignee: Otsuka Chemical Co., Ltd.
    Inventors: Yoshifumi Nakacho, Tadao Yabuhara, Yuji Tada, Yoichi Nishioka
  • Patent number: 6384261
    Abstract: Phosphoramidates and phosphinic amides and related compounds are provided. Also provided are methods that use the compounds for modulating the activity of the endothelin family of peptides are provided. In particular, compounds having formula: in which A, B, R1 and R2 are as described are provided. Also provided are methods for treating endothelin-mediated disorders by administering effective amounts of one or more of these compounds or prodrugs thereof. Methods for elucidating the physiological and pathophysiological roles of endothelin, as well as isolating endothelin receptors are also provided.
    Type: Grant
    Filed: September 3, 1998
    Date of Patent: May 7, 2002
    Assignee: Texas Biotechnology Corporation
    Inventors: Ming Fai Chan, Erik Joel Verner
  • Patent number: 5840917
    Abstract: A phosphorylamide derivative represented by the general formula (I): ##STR1## wherein R represents an amino group that may be substituted, or a salt thereof, possesses potent antibacterial activity against Helicobacter bacterium, especially Helicobacter pylori, and is useful for prevention or treatment of digestive diseases caused by Helicobacter bacterium, solely or in combination with an antacid or an acid secretion inhibitor.
    Type: Grant
    Filed: December 6, 1996
    Date of Patent: November 24, 1998
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Satoru Oi, Hideaki Nagaya, Nobuhiro Inatomi, Masafumi Nakao, Hidefumi Yukimasa
  • Patent number: 5550276
    Abstract: Compounds of the general formula I ##STR1## in which n is 1, 2 or 3 and in which X is oxygen or sulfur, T has the meaning of --S--, --S--S--, --S--S--, --S--S--S--S--, --S--S--S--S--S--, ##STR2## and Y has the meaning of ##STR3## in which Z has the meaning of --H, --COR.sup.13, --COOR.sup.13 or --CONHR.sup.13, and Q has the meaning of oxygen or --NR.sup.0 --, and R.sup.1, R.sup.2, R.sup.0, R.sup.4 and R.sup.13 are as defined in claim 1, with the proviso that the compound of the formula C.sub.2 H.sub.5 --S--CH.sub.2 CH(OH)--P(OC.sub.2 H.sub.5).sub.2 is excepted.The invention also relates to compositions containing the compounds of the formula I and organic materials, for example functional liquids and, in particular, lubricants.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 27, 1996
    Assignee: Ciba-Geigy Corporation
    Inventors: Hermann O. Wirth, Hans-Helmut Friedrich, Kay S. Groninger
  • Patent number: 5260103
    Abstract: Polyphosphazene derivatives containing carbonyl groups and variously alkylated tertiary aminic groups, suited to undergo rapid and efficient photo-crosslinking processes and having general formula: ##STR1## wherein: X represents substituents linked to the polyphosphazene chain by means of hydroxylic or aminic functions and containing carbonyl groups;X' represents additional substituents linked to the polyphosphazene chain by means of hydroxylic or aminic functions and containing one or more variously alkylated tertiary aminic groups;(w+y+z) is an integer ranging from 20 to 15,000;w and z are integers having a value higher than or equal to zero and at any rate lower than 15,000;y is an integer having a value of from 20 to 15,000.
    Type: Grant
    Filed: July 17, 1990
    Date of Patent: November 9, 1993
    Assignee: Consiglio Nazionale Delle Ricerche
    Inventors: Mario Gleria, Francesco Minto, Lucia Flamigni
  • Patent number: 5205852
    Abstract: Herbicidal compounds have the formula ##STR1## in which R is C.sub.3 -C.sub.6 alkyl or C.sub.3 -C.sub.6 cycloalkyl;X is oxygen or sulfur;R.sub.1 is C.sub.1 -C.sub.12 alkyl, C.sub.3 -C.sub.6 cycloalkyl optionally substituted with up to two C.sub.1 -C.sub.3 alkyl groups, phenyl, or substituted phenyl having from 1 to 2 substituents selected from halo, nitro, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 thioalkyl, C.sub.3 -C.sub.4 alkenyl, C.sub.1 -C.sub.4 alkoxycarbonyl, and phenyl;R.sub.2 is hydrogen, C.sub.1 -C.sub.6 alkyl or C.sub.3 -C.sub.6 cycloalkyl; andR.sub.3 is C.sub.2 -C.sub.6 alkyl, C.sub.3 -C.sub.6 cycloalkyl, phenyl or substituted phenyl having from 1 to 2 substituents selected from C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 haloalkyl and halogen;provided that if R.sub.2 is hydrogen, R.sub.3 is not phenyl or substituted phenyl;or R.sub.2 and R.sub.3 taken together with the nitrogen atom form a 4-8 membered ring, optionally including an oxygen heteroatom.
    Type: Grant
    Filed: November 12, 1991
    Date of Patent: April 27, 1993
    Assignee: Imperial Chemical Industries PLC
    Inventors: Michael D. Broadhurst, Tsze H. Tsang
  • Patent number: 5189169
    Abstract: Herbicides having the formula ##STR1## in which X is oxygen or sulfur; and if X is sulfur, R.sub.1 is C.sub.1 -C.sub.6 alkyl, C.sub.5 -C.sub.6 cycloalkyl, allyl, phenyl, tolyl, chlorophenyl, 3,4-dichlorophenyl, or phen-(C.sub.1 -C.sub.2)alkyl; R.sub.2 is C.sub.1 -C.sub.4 alkyl, C.sub.2 -C.sub.4 alkoxyalkyl, or allyl; R.sub.3 is C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxyalkyl, pyridyl, phenyl or substituted phenyl in which the substituents are halogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 haloalkoxy, nitro and/or cyano; or R.sub.2 and R.sub.3 taken together form an alkylene chain having from 2 to 6 carbon atoms optionally substituted by up to two C.sub.1 -C.sub.4 alkyl groups; if R.sub.3 is alkyl or alkoxyalkyl, then R.sub.4 and R.sub.5 are each C.sub.2 -C.sub.4 alkyl; if R.sub.3 is phenyl, substituted phenyl or pyridyl, then R.sub.4 and R.sub.5 are C.sub.2 -C.sub. 6 alkyl, phenyl or substituted phenyl; or R.sub.3 and R.sub.
    Type: Grant
    Filed: November 12, 1991
    Date of Patent: February 23, 1993
    Assignee: Imperial Chemical Industries PLC
    Inventor: David B. Kanne
  • Patent number: 5187266
    Abstract: A compound having the structure: ##STR1## wherein R is CH.sub.3, C.sub.2 H.sub.5, C.sub.3 H.sub.7, t-C.sub.4 H.sub.9 or C.sub.6 H.sub.5 ; R.sup.1 is NH.sub.2, NHCH.sub.3, NHC.sub.2 H.sub.5, NHC.sub.3 H.sub.7, NHC.sub.4 H.sub.9, NHCH.sub.2 CH.sub.2 Cl, NHC.sub.6 H.sub.5, N(CH.sub.3).sub.2, N(C.sub.2 H.sub.5).sub.2, N(C.sub.3 H.sub.7).sub.2, NCH.sub.3 (C.sub.2 H.sub.5), NCH.sub.3 (C.sub.3 H.sub.7), N(CH.sub.2 CH.sub.2 Cl).sub.2, NHOH, NHNHCO.sub.2 CH.sub.2 C.sub.6 H.sub.5, NHNHCO.sub.2 C(CH.sub.3).sub.3, OCH.sub.3, OC.sub.2 H.sub.5, OC.sub.3 H.sub.7, OC.sub.4 H.sub.9, OC.sub.6 H.sub.5, OC.sub.2 C.sub.6 H.sub.5, CH.sub.3, C.sub.2 H.sub.5, C.sub.3 H.sub.7, C.sub.4 H.sub.9, CH.sub.2 NO.sub.2 or CH.sub.2 NH.sub.2 ; and R.sup.2 is NHCH.sub.2 CH.sub.2 Cl or N(CH.sub.2 CH.sub.2 Cl).sub.2.These compounds may be used to eliminate occult leukemic clonogenic cells from bone marrow by contacting the bone marrow with a solution comprising levels of said compound sufficient to eliminate occult leukemic clonogenic cells.
    Type: Grant
    Filed: February 24, 1992
    Date of Patent: February 16, 1993
    Assignee: Board of Regents the University of Texas System
    Inventors: David Farquhar, Yugiang Wang
  • Patent number: 5091552
    Abstract: A compound having the structure: ##STR1## wherein R is CH.sub.3, C.sub.2 H.sub.5, C.sub.3 H.sub.7, t--C.sub.4 H.sub.9 or C.sub.6 H.sub.5 ; R.sup.1 is NH.sub.2, NHCH.sub.3, NHC.sub.2 H.sub.5, NHC.sub.3 H.sub.7, NHC.sub.4 H.sub.9, NHCH.sub.2 CH.sub.2 Cl, NHC.sub.6 H.sub.5, N(CH.sub.3).sub.2, N(C.sub.2 H.sub.5).sub.2, N(C.sub.3 H.sub.7).sub.2, NCH.sub.3 (C.sub.2 H.sub.5), NCH.sub.3 (C.sub.3 H.sub.7), N(CH.sub.2 CH.sub.2 Cl).sub.2, NHOH, NHNHCO.sub.2 CH.sub.2 C.sub.6 H.sub.5, NHNHCO.sub.2 C(CH.sub.3).sub.3, OCH.sub.3, OC.sub.2 H.sub.5, OC.sub.3 H.sub.7, OC.sub.4 H.sub.9, OC.sub.6 H.sub.5, OC.sub.2 C.sub.6 H.sub.5, CH.sub.3, C.sub.2 H.sub.5, C.sub.3 H.sub.7, C.sub.4 H.sub.9, CH.sub.2 NO.sub.2 or CH.sub.2 NH.sub.2 ; and R.sup.2 is NHCH.sub.2 CH.sub.2 Cl or N(CH.sub.2 CH.sub.2 Cl).sub.2.These compounds may be used to eliminate occult leukemic clonogenic cells from bone marrow by contacting the bone marrow with a solution comprising levels of said compound sufficient to eliminate occult leukemic clonogenic cells.
    Type: Grant
    Filed: March 14, 1989
    Date of Patent: February 25, 1992
    Assignee: Board of Regents, The University of Texas System
    Inventor: David Farquhar
  • Patent number: 4652648
    Abstract: Phosphonous acid monoester-monoamides of the formula ##STR1## in which n is 1, R.sub.1 is phenyl, R.sub.2, R.sub.3 and R.sub.4 are independently hydrogen or alkyl, R.sub.5 is alkyl or cyclohexyl, R.sub.6 is 2,2,6,6-tetramethylpiperidin-4-yl or ##STR2## R.sub.3 may also be ##STR3## where X is methylene or isopropylidene and R.sub.6 is alkyl or cyclohexyl. Said compounds are suitable for protecting organic material from the harmful effect of heat, oxygen and light.
    Type: Grant
    Filed: November 13, 1985
    Date of Patent: March 24, 1987
    Assignee: Ciba-Geigy Corporation
    Inventor: Michael Rasberger